Cargando…

Estimation and determinants of direct medical costs of ischaemic heart disease, stroke and hypertensive heart disease: evidence from two major hospitals in Cameroon

BACKGROUND: Cardiovascular disease (CVD) is the largest contributor to the non-communicable diseases (NCD) burden in Cameroon, but data on its economic burden is lacking. METHODS: A prevalence-based cost-of-illness study was conducted from a healthcare provider perspective and enrolled patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Aminde, Leopold Ndemnge, Dzudie, Anastase, Mapoure, Yacouba N., Tantchou, Jacques Cabral, Veerman, J. Lennert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881453/
https://www.ncbi.nlm.nih.gov/pubmed/33579273
http://dx.doi.org/10.1186/s12913-021-06146-4
_version_ 1783650880364478464
author Aminde, Leopold Ndemnge
Dzudie, Anastase
Mapoure, Yacouba N.
Tantchou, Jacques Cabral
Veerman, J. Lennert
author_facet Aminde, Leopold Ndemnge
Dzudie, Anastase
Mapoure, Yacouba N.
Tantchou, Jacques Cabral
Veerman, J. Lennert
author_sort Aminde, Leopold Ndemnge
collection PubMed
description BACKGROUND: Cardiovascular disease (CVD) is the largest contributor to the non-communicable diseases (NCD) burden in Cameroon, but data on its economic burden is lacking. METHODS: A prevalence-based cost-of-illness study was conducted from a healthcare provider perspective and enrolled patients with ischaemic heart disease (IHD), ischaemic stroke, haemorrhagic stroke and hypertensive heart disease (HHD) from two major hospitals between 2013 and 2017. Determinants of cost were explored using multivariate generalized linear models. RESULTS: Overall, data from 850 patients: IHD (n = 92, 10.8%), ischaemic stroke (n = 317, 37.3%), haemorrhagic stroke (n = 193, 22.7%) and HHD (n = 248, 29.2%) were analysed. The total cost for these CVDs was XAF 676,694,000 (~US$ 1,224,918). The average annual direct medical costs of care per patient were XAF 1,395,200 (US$ 2400) for IHD, XAF 932,700 (US$ 1600) for ischaemic stroke, XAF 815,400 (US$ 1400) for haemorrhagic stroke, and XAF 384,300 (US$ 700) for HHD. In the fully adjusted models, apart from history of CVD event (β = − 0.429; 95% confidence interval − 0.705, − 0.153) that predicted lower costs in patients with IHD, having of diabetes mellitus predicted higher costs in patients with IHD (β = 0.435; 0.098, 0.772), ischaemic stroke (β = 0.188; 0.052, 0.324) and HHD (β = 0.229; 0.080, 0.378). CONCLUSIONS: This study reveals substantial economic burden due to CVD in Cameroon. Diabetes mellitus was a consistent driver of elevated costs across the CVDs. There is urgent need to invest in cost-effective primary prevention strategies in order to reduce the incidence of CVD and consequent economic burden on a health system already laden with the impact of communicable diseases. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12913-021-06146-4.
format Online
Article
Text
id pubmed-7881453
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-78814532021-02-17 Estimation and determinants of direct medical costs of ischaemic heart disease, stroke and hypertensive heart disease: evidence from two major hospitals in Cameroon Aminde, Leopold Ndemnge Dzudie, Anastase Mapoure, Yacouba N. Tantchou, Jacques Cabral Veerman, J. Lennert BMC Health Serv Res Research Article BACKGROUND: Cardiovascular disease (CVD) is the largest contributor to the non-communicable diseases (NCD) burden in Cameroon, but data on its economic burden is lacking. METHODS: A prevalence-based cost-of-illness study was conducted from a healthcare provider perspective and enrolled patients with ischaemic heart disease (IHD), ischaemic stroke, haemorrhagic stroke and hypertensive heart disease (HHD) from two major hospitals between 2013 and 2017. Determinants of cost were explored using multivariate generalized linear models. RESULTS: Overall, data from 850 patients: IHD (n = 92, 10.8%), ischaemic stroke (n = 317, 37.3%), haemorrhagic stroke (n = 193, 22.7%) and HHD (n = 248, 29.2%) were analysed. The total cost for these CVDs was XAF 676,694,000 (~US$ 1,224,918). The average annual direct medical costs of care per patient were XAF 1,395,200 (US$ 2400) for IHD, XAF 932,700 (US$ 1600) for ischaemic stroke, XAF 815,400 (US$ 1400) for haemorrhagic stroke, and XAF 384,300 (US$ 700) for HHD. In the fully adjusted models, apart from history of CVD event (β = − 0.429; 95% confidence interval − 0.705, − 0.153) that predicted lower costs in patients with IHD, having of diabetes mellitus predicted higher costs in patients with IHD (β = 0.435; 0.098, 0.772), ischaemic stroke (β = 0.188; 0.052, 0.324) and HHD (β = 0.229; 0.080, 0.378). CONCLUSIONS: This study reveals substantial economic burden due to CVD in Cameroon. Diabetes mellitus was a consistent driver of elevated costs across the CVDs. There is urgent need to invest in cost-effective primary prevention strategies in order to reduce the incidence of CVD and consequent economic burden on a health system already laden with the impact of communicable diseases. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12913-021-06146-4. BioMed Central 2021-02-12 /pmc/articles/PMC7881453/ /pubmed/33579273 http://dx.doi.org/10.1186/s12913-021-06146-4 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Aminde, Leopold Ndemnge
Dzudie, Anastase
Mapoure, Yacouba N.
Tantchou, Jacques Cabral
Veerman, J. Lennert
Estimation and determinants of direct medical costs of ischaemic heart disease, stroke and hypertensive heart disease: evidence from two major hospitals in Cameroon
title Estimation and determinants of direct medical costs of ischaemic heart disease, stroke and hypertensive heart disease: evidence from two major hospitals in Cameroon
title_full Estimation and determinants of direct medical costs of ischaemic heart disease, stroke and hypertensive heart disease: evidence from two major hospitals in Cameroon
title_fullStr Estimation and determinants of direct medical costs of ischaemic heart disease, stroke and hypertensive heart disease: evidence from two major hospitals in Cameroon
title_full_unstemmed Estimation and determinants of direct medical costs of ischaemic heart disease, stroke and hypertensive heart disease: evidence from two major hospitals in Cameroon
title_short Estimation and determinants of direct medical costs of ischaemic heart disease, stroke and hypertensive heart disease: evidence from two major hospitals in Cameroon
title_sort estimation and determinants of direct medical costs of ischaemic heart disease, stroke and hypertensive heart disease: evidence from two major hospitals in cameroon
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881453/
https://www.ncbi.nlm.nih.gov/pubmed/33579273
http://dx.doi.org/10.1186/s12913-021-06146-4
work_keys_str_mv AT amindeleopoldndemnge estimationanddeterminantsofdirectmedicalcostsofischaemicheartdiseasestrokeandhypertensiveheartdiseaseevidencefromtwomajorhospitalsincameroon
AT dzudieanastase estimationanddeterminantsofdirectmedicalcostsofischaemicheartdiseasestrokeandhypertensiveheartdiseaseevidencefromtwomajorhospitalsincameroon
AT mapoureyacouban estimationanddeterminantsofdirectmedicalcostsofischaemicheartdiseasestrokeandhypertensiveheartdiseaseevidencefromtwomajorhospitalsincameroon
AT tantchoujacquescabral estimationanddeterminantsofdirectmedicalcostsofischaemicheartdiseasestrokeandhypertensiveheartdiseaseevidencefromtwomajorhospitalsincameroon
AT veermanjlennert estimationanddeterminantsofdirectmedicalcostsofischaemicheartdiseasestrokeandhypertensiveheartdiseaseevidencefromtwomajorhospitalsincameroon